Kennedy Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-149,151	Closed	-$577K	–	693
2020 Q3	$577K	Buy	149,151 +47,764	+47%	+$185K	0.02%	583
2020 Q2	$384K	Buy	+101,387	New	+$384K	0.01%	616